IRIDEX CORP Form 8-K Summary
Business Context and Reporting Period
IRIDEX Corporation (Nasdaq: IRIX) filed this Current Report on August 10, 2023, to announce its financial results for the second fiscal quarter of fiscal year 2023, which ended on July 1, 2023. The company is incorporated in Delaware and operates from Mountain View, California.
Financial Metrics
This Form 8-K serves as a notification of the results and incorporates the press release (Exhibit 99.1) by reference. The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached press release for detailed financial data.
Material Changes
The filing does not contain specific comparative data or details regarding material changes versus the prior comparable period within the body of the report. Such information is contained in the referenced press release.
Guidance, Outlook, and Risks
The document does not include management commentary, forward-looking guidance, risk factors, or contingencies. It explicitly states that the information is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, except as expressly set forth by specific reference.
Key Facts for Investor Verification
- Verify the specific revenue and net income figures in the press release dated August 10, 2023 (Exhibit 99.1).
- Confirm the company's cash position and liquidity status as detailed in the referenced exhibit.
- Review the press release for any updates on product pipeline, regulatory approvals, or strategic initiatives not detailed in this summary.
- Note that this 8-K is a procedural filing referencing external data rather than a standalone financial statement.